Journal of Clinical & Medical Genomics

The Promise and Perils of Direct-to-Consumer Genetic Testing in Clinical Practice

Abstract

Akkari Anthena

In recent years, Direct-To-Consumer (DTC) genetic testing has garnered
significant attention, offering individuals the ability to access their genetic
information without the need for a healthcare provider’s involvement.
Companies such as 23andMe, Ancestry DNA, and others have popularized
this concept, allowing consumers to gain insights into their ancestry, genetic
predispositions to health conditions, and traits. While DTC genetic testing
holds tremendous promise, it also presents a range of challenges that can
complicate its integration into clinical practice.